Results 241 to 250 of about 463,262 (274)
Some of the next articles are maybe not open access.
An additional recommendation on reporting depression
American Journal of Psychiatry, 1984J A, Hamilton, R M, Hirschfeld
openaire +2 more sources
Reboxetine: additional benefits to the depressed patient.
Journal of psychopharmacology (Oxford, England), 1998Reboxetine is a new selective noradrenaline reuptake inhibitor that has been shown to be effective in both the short-(4-8 weeks) and long-term (up to 12 months) treatment of depression. Four positive placebo-controlled studies showed reboxetine to have significant antidepressant efficacy; the response rate (> or = 50% decrease in HAM-D total score ...
openaire +1 more source
Lithium Addition in Treatment-Resistant Depression
The Canadian Journal of Psychiatry, 1986C, de Montigng +2 more
openaire +2 more sources
Addition of Olanzapine for Treatment-Resistant Depression
American Journal of Psychiatry, 2001WILLIAM PITCHOT, MARC ANSSEAU
openaire +1 more source
Respiratory Depression with Addition of Fentanyl to Spinal Anesthesia
Anesthesia & Analgesia, 1997Spencer S. Liu +4 more
openaire +2 more sources

